Highlights and Quick Summary
- Non-operating Income/Expense for the quarter ending May 31, 2022 was $-13 Million (a -18.58% decrease compared to previous quarter)
- Year-over-year quarterly Non-operating Income/Expense increased by 3661.22%
- Annual Non-operating Income/Expense for 2021 was $6.6 Million (a -121.61% decrease from previous year)
- Annual Non-operating Income/Expense for 2020 was $-30.5 Million (a -44.88% decrease from previous year)
- Annual Non-operating Income/Expense for 2019 was $-55.4 Million (a 38.83% increase from previous year)
- Twelve month Non-operating Income/Expense ending May 31, 2022 was $-47.9 Million (a -11.42% decrease compared to previous quarter)
- Twelve month trailing Non-operating Income/Expense decreased by -10.2% year-over-year
Trailing Non-operating Income/Expense for the last four month:
| 31 May '22 | 28 Feb '22 | 30 Nov '21 | 31 Aug '21 |
|---|---|---|---|
| $-47.9 Million | $-54.1 Million | $-67.2 Million | $-53.3 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Income/Expense of Organigram Holdings Inc.
Most recent Non-operating Income/Expenseof OGI including historical data for past 10 years.Interactive Chart of Non-operating Income/Expense of Organigram Holdings Inc.
Organigram Holdings Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-13.04 | $-16.02 | – | – | – |
| 2021 | $-18.48 | $-0.35 | $-19.22 | $-29.12 | $6.6 |
| 2020 | $-4.65 | $2.83 | $-0.38 | $-2.66 | $-30.51 |
| 2019 | $-0.62 | $-0.77 | $-0.85 | $-3.93 | $-55.36 |
| 2018 | – | – | – | $-3.01 | $-39.88 |
| 2017 | – | – | – | – | $1.08 |
| 2016 | – | – | – | – | $-0.22 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic